Wedbush Starts Cerus (CERS) at Outperform; Time To Get Serious
Tweet
Share
E-mailGet Alerts CERS Hot Sheet
Price: $2.98 +4.93%
Rating Summary:
6 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
6 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Wedbush initiates coverage on Cerus (NASDAQ: CERS) with a Outperform. PT $4.
Wedbush analyst said, "Cerus’ INTERCEPT system keeps the blood supply safe by neutralizing viruses (known & unknown) and bacteria. Leads competitors with broadest platform, better tech and most data...Opportunities for upside exist, with potentially greater traction in Germany, potential new tenders in France, & other EU traction. Go-ahead from FDA on US platelet initiative could be positive catalyst in 2011...CERS veteran, Obi Greenman, was appointed CEO in 2Q11, bringing new energy to the company and FDA conversations, in our view. Chief Scientific Officer, Dr. Corash made large share purchases in May which could be a positive indicator."
For more ratings news on Cerus click here and for the rating history of Cerus click here.
Shares of Cerus closed at $2.88 yesterday.
Wedbush analyst said, "Cerus’ INTERCEPT system keeps the blood supply safe by neutralizing viruses (known & unknown) and bacteria. Leads competitors with broadest platform, better tech and most data...Opportunities for upside exist, with potentially greater traction in Germany, potential new tenders in France, & other EU traction. Go-ahead from FDA on US platelet initiative could be positive catalyst in 2011...CERS veteran, Obi Greenman, was appointed CEO in 2Q11, bringing new energy to the company and FDA conversations, in our view. Chief Scientific Officer, Dr. Corash made large share purchases in May which could be a positive indicator."
For more ratings news on Cerus click here and for the rating history of Cerus click here.
Shares of Cerus closed at $2.88 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)
- Evercore ISI Starts Alvotech SA (ALVO) at Outperform
- Oppenheimer Starts Carriage Services (CSV) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
